scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41388-018-0449-Z |
P698 | PubMed publication ID | 30158673 |
P2093 | author name string | George Miller | |
N Joseph Espat | |||
Steven C Katz | |||
Prajna Guha | |||
Richard P Junghans | |||
Matthew Lima | |||
Marissa Cunetta | |||
Jillian Gardell | |||
Josephine Darpolor | |||
P2860 | cites work | Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death | Q24312211 |
p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-kappaB activity and Fas expression | Q28115373 | ||
Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
IL-23 promotes tumour incidence and growth | Q28239522 | ||
Apoptosis: a review of programmed cell death | Q28305845 | ||
Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice | Q28385532 | ||
Bax suppresses tumorigenesis and stimulates apoptosis in vivo | Q28506493 | ||
The Bax N terminus is required for negative regulation by the mitogen-activated protein kinase kinase and Akt signaling pathways in T cells | Q28592278 | ||
The STATs of cancer--new molecular targets come of age | Q29614601 | ||
Stattic: a small-molecule inhibitor of STAT3 activation and dimerization | Q33264035 | ||
Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases. | Q33724135 | ||
Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor | Q33805313 | ||
IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways | Q33888307 | ||
The role of interleukin-2 during homeostasis and activation of the immune system | Q34255232 | ||
Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway | Q34314210 | ||
Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects. | Q34473451 | ||
Stat proteins and oncogenesis | Q34627064 | ||
GM-CSF in inflammation and autoimmunity. | Q34754737 | ||
Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell–expressed FasL | Q35029951 | ||
Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis | Q35035620 | ||
Suppression of cancer relapse and metastasis by inhibiting cancer stemness | Q35090120 | ||
Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells | Q35134007 | ||
NF-κB and STAT3 – key players in liver inflammation and cancer | Q35347976 | ||
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression | Q35478848 | ||
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T | Q35798161 | ||
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells. | Q35799094 | ||
Fas/FasL interaction: a novel immune therapy approach with immobilized biologicals | Q35984883 | ||
Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells | Q35987390 | ||
Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling. | Q36302820 | ||
Transcriptional regulation of myeloid-derived suppressor cells | Q36322351 | ||
Signal transducer and activator of transcription 5 (STAT5), a crucial regulator of immune and cancer cells | Q36352260 | ||
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function | Q36384598 | ||
Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice. | Q36410807 | ||
Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases | Q36564552 | ||
Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis | Q36564701 | ||
Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer. | Q36967364 | ||
Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. | Q37087293 | ||
Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment | Q37169987 | ||
The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression | Q37253328 | ||
Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery | Q37497357 | ||
Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis | Q37744890 | ||
Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC). | Q38006616 | ||
PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells | Q38047052 | ||
Shaping gene expression in activated and resting primary macrophages by IL-10. | Q38363550 | ||
The phosphatidylinositol 3-kinase/Akt and c-Jun N-terminal kinase signaling in cancer: Alliance or contradiction? (Review). | Q38529820 | ||
Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin | Q38792113 | ||
Immunosuppression in liver tumors: opening the portal to effective immunotherapy. | Q39026963 | ||
Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer | Q39107664 | ||
5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity | Q39715226 | ||
Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases | Q39751334 | ||
Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2. | Q39876429 | ||
Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53. | Q40138858 | ||
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity | Q40351340 | ||
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity | Q40372686 | ||
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells | Q40519826 | ||
Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils | Q40591759 | ||
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells | Q40602668 | ||
p38 mitogen-activated protein kinase is involved in Fas ligand expression. | Q40932801 | ||
JNK activation is not required for Fas-mediated apoptosis | Q40944633 | ||
Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. | Q41075660 | ||
Role of apoptosis resistance in immune evasion and metastasis of colorectal cancer | Q41114891 | ||
Mitochondrial control of apoptosis | Q41339880 | ||
Bcl-2 and the ICE family of apoptotic regulators: making a connection. | Q41345463 | ||
Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins | Q47997557 | ||
Frontline Science: Functionally impaired geriatric CAR-T cells rescued by increased α5β1 integrin expression | Q50032034 | ||
Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance | Q57174100 | ||
Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors | Q58034341 | ||
Fas- or Ceramide-induced Apoptosis Is Mediated by a Rac1-regulated Activation of Jun N-terminal Kinase/p38 Kinases and GADD153 | Q73617992 | ||
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells | Q80274418 | ||
T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases | Q84150373 | ||
P433 | issue | 4 | |
P304 | page(s) | 533-548 | |
P577 | publication date | 2018-08-29 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells | |
P478 | volume | 38 |
Q97067646 | CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape |
Q90321041 | Candesartan ameliorates vascular smooth muscle cell proliferation via regulating miR-301b/STAT3 axis |
Q92977405 | Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities |
Q92375496 | Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling |
Q90092950 | Jianpi Huayu Decoction Attenuates the Immunosuppressive Status of H22 Hepatocellular Carcinoma-Bearing Mice: By Targeting Myeloid-Derived Suppressor Cells |
Q96231527 | Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies |
Q92731408 | Modulation of Immunosuppression by Oligonucleotide-Based Molecules and Small Molecules Targeting Myeloid-Derived Suppressor Cells |
Q102369377 | Monocytic and granulocytic myeloid-derived suppressor cell plasticity and differentiation are organ-specific |
Q97883099 | P-STAT3 Inhibition Activates Endoplasmic Reticulum Stress-Induced Splenocyte Apoptosis in Chronic Stress |
Q92863682 | PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF-κB pathway |
Q97526934 | Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression |
Q93079065 | STAT3, a Master Regulator of Anti-Tumor Immune Response |
Q98289192 | STAT3-PTTG11 abrogation inhibits proliferation and induces apoptosis in malignant glioma cells |
Q64099576 | The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics |
Q97644531 | Upregulated TRAIL and Reduced DcR2 Mediate Apoptosis of Decidual PMN-MDSC in Unexplained Recurrent Pregnancy Loss |
Search more.